Results 71 to 80 of about 19,792 (313)

The PARP inhibitor PJ-34 sensitizes cells to UVA-induced phototoxicity by a PARP independent mechanism [PDF]

, 2016
K
Hegedűs, Csaba, Juarranz, Ángeles, Kövér, Katalin, E., Lakatos, Petra, Salazar Ayestarán, Nerea, Szabó, Éva, Virág, László   +6 more
core   +1 more source

Nueve años de experiencia en el tratamiento de micosis fungoides con PUVA en el Hospital Militar Central

Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 2001
a micosis fungoides (MF) es un linfoma de cé lulas T no Hodking de la piel, que frecuentemente empieza como parches y placas limitadas, con crecimiento progresivo hasta compromiso sistémico.
María Claudia Torres, Gaby Teresa Flórez, Patricia Escobar, Hernán Mejía, Martha PArdo, Natalia Hernández, Olga Pardo, Luisa Mota, Martha Robayo, Luz Pabón, William Rivera, Alvaro Sandoval, Héctor Samacá, Bernardo Castro, Margarita Vargas   +14 more
doaj  

Mycosis fungoides with CD20 expression: report of two cases and review of the literature [PDF]

, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107359/1/cup12299 ...
Arai, Balmer, Benner, Blakolmer, Bubien, Chiang, Chui, Edinger, Glusac, Hagen, Hirata, Hultin, Jullie, Landa, Magro, Maloney, Martin, Metzman, Murayama, Noe, Olsen, Plaza, Rahemtullah, Sen, Song, Stein, Sun, Zackheim   +27 more
core   +1 more source

Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A

Acta Dermato-Venereologica, 2018
Data on the treatment of early folliculotropic mycosis fungoides, a recently defined clinicopathological subgroup of folliculotropic mycosis fungoides with an indolent course, is limited.
Iris Amitay-Laish, Hadas Prag-Naveh, Adam Dalal, Lev Pavlovsky, Meora Feinmesser, Emmilia Hodak   +5 more
doaj   +1 more source

Photodynamic Therapy for Granuloma Annulare: More than a Shot in the Dark [PDF]

, 2008
Granuloma annulare (GA) is a benign granulomatous and inflammatory skin disorder. The pathogenesis remains enigmatic and convincingly effective treatment options are not available.
Berking, Carola, Kuznetsov, Alexander Vasilevic, Molin, Sonja, Prinz, Jörg Christoph, Ruzicka, Thomas, Weisenseel, Peter   +5 more
core   +1 more source

An Early Record of Photochemotherapy for Vitiligo by Rhazes (865–925 ce) in Liber Continens

JEADV Clinical Practice, EarlyView.
Alireza Tavakkoli
wiley   +1 more source

Efficacy and Safety of Conventional and Biologic Therapies in Prurigo Nodularis: A Systematic Review and Meta‐Analysis

International Journal of Dermatology, EarlyView.
ABSTRACT Prurigo nodularis (PN) is a chronic, intensely pruritic skin disorder characterized by hyperkeratotic nodules and a debilitating itch–scratch cycle. Conventional therapies have limited efficacy and safety issues, while biologics have recently emerged as a promising alternative.
Andrea Lancz, Fanni Adél Meznerics, Renáta Árok, Anna Sára Lengyel, Bence Szabó, Péter Hegyi, Norbert Kiss, András Bánvölgyi   +7 more
wiley   +1 more source

Evaluation of PUVA-induced skin side effects in patients referred to the Imam Reza Hospital of Mashhad in 2005-2007

Indian Journal of Dermatology, 2014
Background: Systemic oral psoralens plus UVA therapy (PUVA) is a therapeutic method used with considerable success in many different skin disorders. PUVA therapy causes some cutaneous and noncutaneous side effects and in the present research we deal with
Masoud Maleki, Mohammad Javad Yazdanpanah, Hamid Hamidi, Leila Jokar   +3 more
doaj   +1 more source

Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.

Indian Journal of Dermatology, Venereology and Leprology, 2010
BACKGROUND Psoralen UV-A (PUVA) is an established therapy for psoriasis, but there is a well-documenated risk of melanoma and nonmelanoma skin cancer.
S. Dayal, Mayanka, V. Jain
semanticscholar   +1 more source

scRNA‐Seq reveals anti‐lymphoma immune responses in mogamulizumab‐associated skin eruptions

Journal of the European Academy of Dermatology and Venereology, EarlyView.
CCR4 was expressed in malignant clones and regulatory T cells in untreated CTCL, that were decreased in MAR. Malignant clones in MAR showed a silenced phenotype with decreases in central memory markers SELL and CCR7, and GTP‐binding member GIMAP7 and upregulation of MMP2 inhibitor TIMP2 and tumour suppressor gene RUNX3.
Shannon Meledathu, Agata Kurowski, Malini P. Naidu, Jonas Adalsteinsson, Shane A. Meehan, Natalia Alkon, Lauren R. Port, Sumanth Chennareddy, Emry R. Cohenour, Grace Christensen, Jonah Shulman, Nicholas Gulati, Constanze Jonak, Patrick M. Brunner   +13 more
wiley   +1 more source